Over 50% of Hospital CFOs Plan to Adopt New Technology in Response to Medicare Cuts for Cardiac Device Infections
08:00 EDT 20 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Medicare’s decision to stop reimbursing hospitals for the treatment of
potentially avoidable surgical site infections following cardiac
implantable electronic device (CIED) procedures, including pacemaker and
defibrillator imp...
Other Sources for this Article
Company:
TYRX, Inc.
Robert White, 732-246-8676
President
and Chief Executive Officer
info@TYRX.com
or
Media:
Kureczka/Martin
Associates
Joan Kureczka, 415-690-0210
Joan@Kureczka-Martin.com
More From BioPortfolio on "Over 50% of Hospital CFOs Plan to Adopt New Technology in Response to Medicare Cuts for Cardiac Device Infections"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
